Loading
Latest filing published 19 Jan 2023 for Kindstar Globalgene Technology, Inc., €162. Read the official filing
Based on 29 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Huang Shiang appears in our data through filings on Kindstar Globalgene Technology, Inc. shares, published by HKEX. We count 29 filings; the first trade dates from 10 May 2022 and the latest from 13 July 2022.
Purchases make up the whole of the open-market record (29 purchases, €291k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2023, the count stands at 1 purchase and no sales.
A typical purchase (the median) is worth €6,220. None of the 29 purchases we analysed coincided with buying by another insider of the same company within 30 days. After 29 purchases with a full 90-day history, the hit rate stands at 24% and the median 90-day move at -5.0%. Past outcomes like these are no guarantee of what comes next.
The record was last updated on 19 January 2023 with an open-market purchase (€162) in Kindstar Globalgene Technology, Inc. Filings reach the HKEX feed a median of 2 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. Source: insider filings from HKEX. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 29 declarations